Legal & General Group’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-59,137
| Closed | -$4.72M | – | 3761 |
|
|
2021
Q1 | $4.72M | Buy |
59,137
+1,653
| +3% | +$129K | ﹤0.01% | 1581 |
|
|
2020
Q4 | $4.53M | Buy |
57,484
+2,748
| +5% | +$161K | ﹤0.01% | 1503 |
|
|
2020
Q3 | $2.41M | Buy |
54,736
+1,333
| +2% | +$65.7K | ﹤0.01% | 1687 |
|
|
2020
Q2 | $2.36M | Sell |
53,403
-1,866
| -3% | -$69.6K | ﹤0.01% | 1660 |
|
|
2020
Q1 | $1.98M | Buy |
55,269
+895
| +2% | +$50.9K | ﹤0.01% | 1587 |
|
|
2019
Q4 | $3.85M | Buy |
54,374
+4,660
| +9% | +$338K | ﹤0.01% | 1504 |
|
|
2019
Q3 | $3.72M | Buy |
49,714
+5,765
| +13% | +$489K | ﹤0.01% | 1440 |
|
|
2019
Q2 | $3.54M | Buy |
43,949
+73
| +0.2% | +$5.13K | ﹤0.01% | 1445 |
|
|
2019
Q1 | $2.94M | Buy |
43,876
+389
| +0.9% | +$29.5K | ﹤0.01% | 1502 |
|
|
2018
Q4 | $3.24M | Buy |
43,487
+1,362
| +3% | +$112K | ﹤0.01% | 1323 |
|
|
2018
Q3 | $3.88M | Buy |
42,125
+904
| +2% | +$86.1K | ﹤0.01% | 1339 |
|
|
2018
Q2 | $4.05M | Buy |
41,221
+4,090
| +11% | +$457K | ﹤0.01% | 1256 |
|
|
2018
Q1 | $4.14M | Sell |
37,131
-36,543
| -50% | -$4.1M | ﹤0.01% | 1191 |
|
|
2017
Q4 | $7.58M | Buy |
73,674
+1,685
| +2% | +$168K | 0.01% | 886 |
|
|
2017
Q3 | $6.77M | Buy |
71,989
+2,135
| +3% | +$169K | 0.01% | 895 |
|
|
2017
Q2 | $5.44M | Buy |
69,854
+6,767
| +11% | +$508K | ﹤0.01% | 944 |
|
|
2017
Q1 | $5.05M | Buy |
63,087
+83
| +0.1% | +$6.6K | ﹤0.01% | 929 |
|
|
2016
Q4 | $4.96M | Buy |
63,004
+30,422
| +93% | +$2.36M | ﹤0.01% | 893 |
|
|
2016
Q3 | $2.54M | Buy |
32,582
+24,903
| +324% | +$1.81M | ﹤0.01% | 934 |
|
|
2016
Q2 | $527K | Buy |
7,679
+347
| +5% | +$23.9K | ﹤0.01% | 1330 |
|
|
2016
Q1 | $520K | Buy |
7,332
+779
| +12% | +$48.9K | ﹤0.01% | 1298 |
|
|
2015
Q4 | $410K | Hold |
6,553
| – | – | ﹤0.01% | 1392 |
|
|
2015
Q3 | $364K | Hold |
6,553
| – | – | ﹤0.01% | 1393 |
|
|
2015
Q2 | $352K | Buy |
6,553
+513
| +8% | +$25K | ﹤0.01% | 1462 |
|
|
2015
Q1 | $288K | Buy |
6,040
+1,147
| +23% | +$50.8K | ﹤0.01% | 1508 |
|
|
2014
Q4 | $216K | Hold |
4,893
| – | – | ﹤0.01% | 1524 |
|
|
2014
Q3 | $173K | Buy |
+4,893
| New | +$173K | ﹤0.01% | 1582 |
|
Legal & General Group's CMD Position: Q2 2021 in Review
Legal & General Group sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 59,137 shares — an estimated $4.72M sold.
Legal & General Group first reported a position in CMD in Q3 2014 and held it in 27 quarters. The position peaked at $7.58M in Q4 2017. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Legal & General Group reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Legal & General Group sold 59,137 Cantel Medical Corporation shares in Q2 2021, an estimated $4.72M.
- Legal & General Group first reported a position in Cantel Medical Corporation in Q3 2014 and held it in 27 quarters.
- Legal & General Group's Cantel Medical Corporation position peaked at $7.58M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Legal & General Group's 13F filing for Q2 2021, filed 12 Aug 2021.